Cancer Immunotherapy Clinical Trials: Patient Perspectives

webinar-registration_large_banner_image_740x300.png

In this webinar designed for patients and caregivers, three cancer survivors share their experiences receiving immunotherapy in a clinical trial and answer viewer questions.

Carol Roth, diagnosed in 2015 with stage 4 glioblastoma; Jami Cameron, diagnosed with non-Hodgkin lymphoma in 1994; and Janie Ferling, diagnosed with stage 3 metastatic melanoma in 2013, enrolled in immunotherapy clinical trials that helped them bring cancer back under control.

Our 2017 "Cancer Immunotherapy and You" webinar series is made possible with generous support from Genentech, Bristol-Myers Squibb, Advaxis, and Regeneron.

Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

Father and son